Aug 6, 2026 08:22AM
Jul 6, 2026 08:03AM
May 19, 2026 08:30AM
May 7, 2026 08:03AM
Mar 23, 2026 11:00AM
Mar 23, 2026 08:03AM
Feb 26, 2026 06:06AM Aurinia Pharmaceuticals (AUPH) Tops Q4 EPS by $1.38, provides guidance
Dec 3, 2025 06:40AM
Nov 7, 2025 02:50AM
Nov 4, 2025 04:43PM
Nov 4, 2025 06:01AM
Oct 15, 2025 06:01AM
Sep 30, 2025 05:01AM
Sep 30, 2025 02:37AM Jefferies Reiterates Hold Rating on Aurinia Pharmaceuticals (AUPH)
Aug 4, 2025 05:28AM
Jul 31, 2025 06:03AM
Jul 30, 2025 06:34AM
Jun 30, 2025 01:10PM
Jun 30, 2025 01:09PM
Jun 30, 2025 06:01AM
May 12, 2025 08:21AM Leerink Partners Reiterates Outperform Rating on Aurinia Pharmaceuticals (AUPH)
May 12, 2025 06:08AM
Feb 27, 2025 06:01AM
Nov 11, 2024 06:20AM
Nov 7, 2024 02:04PM
Nov 7, 2024 09:08AM
Nov 7, 2024 06:10AM
Nov 7, 2024 06:02AM Aurinia Pharmaceuticals (AUPH) Tops Q3 EPS by 8c ; Offers Guidance
Oct 11, 2024 06:01AM
Sep 24, 2024 08:10AM
Sep 12, 2024 04:05PM
Sep 6, 2024 06:53AM
Sep 5, 2024 07:22AM
Aug 13, 2024 08:00AM
Aug 1, 2024 06:04AM Aurinia Pharmaceuticals (AUPH) Reports In-Line Q2 EPS, narrows guidance

435,754 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All